Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNiox Group Regulatory News (NIOX)

Share Price Information for Niox Group (NIOX)

Share Price is delayed by 15 minutes
Get Live Data
61.00    2.00 (3.39%)
Bid:
60.40
Ask:
61.80
Spread: 1.40 (2.318%)
Market Cap: £256.73m
NIOX Live PriceLast checked at - London Stock Exchange

Intraday Niox Group Share Chart

Exercise of SAYE Options

27 Mar 2024 14:00

RNS Number : 5601I
Niox Group PLC
27 March 2024

NIOX Group plc

Exercise of SAYE Options

27 March 2024

NIOX Group plc (the "Company") (AIM: NIOX) today announces that on 27 March 2024 options over a total of 336,937 ordinary shares of 0.08p in the Company ("Ordinary Shares") were exercised under the terms of the NIOX Group plc Save As You Earn Scheme 2020 - UK ("SAYE"). The total includes 245,343 options exercised by the following directors:

Number of SAYE options exercised

Exercise price per Ordinary Share (pence)

Amount paid (£)

Ian Johnson

81,781

22.01

18,000

Jonathan Emms

81,781

22.01

18,000

Michael Roller

81,781

22.01

18,000

245,343

54,000

The new Ordinary Shares issued in connection with the exercise of options under the SAYE are subject to an existing block admission and rank pari passu with the existing Ordinary Shares.

Voting rights

Following these transactions, Ian Johnson holds 791,601 Ordinary Shares, Jonathan Emms holds 791,867 Ordinary Shares and Michael Roller holds 581,903 Ordinary Shares. This equates to 0.19%, 0.19% and 0.14% of the total voting rights of the Company respectively.

Following the issue of the 336,937 Ordinary shares under the SAYE scheme and the issue of an additional 289,136 Ordinary shares granted under the PSP scheme earlier this month the Company's issued share capital now consists of 422,746,703 Ordinary Shares, each carrying one voting right. Therefore, the total number of voting rights in the Company is 422,746,703. This number may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

Additional disclosure in relation to PDMR dealing is included at the end of this announcement.

For further information, please contact:

NIOX Group plc

Ian Johnson, Executive Chairman

Michael Roller, Chief Financial Officer

Sarah Duncan, Company Secretary

+44 (0) 3303 309 356

Singer Capital Markets (Nominated Adviser & Broker)

Aubrey Powell / Jen Boorer / James Todd

+44 (0) 20 7496 3000

Investec Bank plc

Edward Knight / Bruce Garrow / Lydia Zychowska

+44 (0) 20 7597 4000

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

1. Ian Johnson

2. Jonathan Emms

3. Michael Roller

2.

Reason for the notification

a.

Position/status

1. Executive Chairman

2. Chief Operating Officer

3. Chief Financial Officer

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

NIOX Group plc

b.

LEI

2138006YAT138TOGA556

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary Shares of 0.08p each

GB00BJVD3B28

b.

Nature of the transaction

Issue of new Ordinary Shares

c.

Price(s) and volume(s)

Price(s)

Volume(s)

1. 22.01p

2. 22.01p

3. 22.01p

1. 81,781

2. 81,781

3. 81,781

d.

Aggregated information

· Aggregated volume

· Price

n/a

e.

Date of the transaction

27/03/2024

f.

Place of the transaction

London Stock Exchange, AIM

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHPPUBCWUPCGWM
Date   Source Headline
1st Jun 20261:51 pmRNSTotal Voting Rights
29th May 20263:57 pmRNSDirector/PDMR Shareholding
21st May 20262:47 pmRNSResult of AGM
21st May 20267:00 amRNSAGM Statement
5th May 20264:22 pmRNSGrant of SAYE options
1st May 20264:46 pmRNSTotal Voting Rights
24th Apr 20265:20 pmRNSDividend Timetable
21st Apr 202612:18 pmRNSDirector/PDMR Shareholding
21st Apr 202610:23 amRNSNotice of 2026 Annual General Meeting
17th Apr 20265:59 pmRNSExercise of Options, Director Dealing and TVR
9th Apr 20261:55 pmRNSGrant of Options
1st Apr 20267:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
24th Mar 20263:22 pmRNSHolding(s) in Company
24th Mar 20267:00 amRNSFinal Results
16th Mar 20264:30 pmRNSBlock Listing Application
27th Feb 20269:41 amRNSTotal Voting Rights
30th Jan 202610:04 amRNSTotal Voting Rights
21st Jan 20265:28 pmRNSHolding(s) in Company
20th Jan 20267:00 amRNSFull Year Trading Update
16th Jan 20268:15 amRNSReplacement: Block Listing Application
16th Jan 20267:00 amRNSBlock Listing Application
31st Dec 20259:47 amRNSTotal Voting Rights
31st Dec 20259:47 amRNSTotal Voting Rights
4th Dec 20257:00 amRNSDirector/PDMR Shareholding
1st Dec 202510:29 amRNSHolding(s) in Company
26th Nov 202511:52 amRNSBlock Listing Application
31st Oct 20252:24 pmRNSTotal Voting Rights
8th Oct 20251:08 pmRNSHolding(s) in Company
2nd Oct 20252:11 pmRNSHolding(s) in Company
1st Oct 20253:55 pmRNSBlock listing Interim Review
1st Oct 20253:00 pmRNSTotal Voting Rights
30th Sep 20257:00 amRNSINTERIM RESULTS
19th Sep 20252:16 pmRNSHolding(s) in Company
1st Sep 20253:41 pmRNSTotal Voting Rights
12th Aug 202512:21 pmRNSHolding(s) in Company
6th Aug 202510:35 amRNSHolding(s) in Company
1st Aug 20257:00 amRNSTotal Voting Rights
22nd Jul 20251:48 pmRNSPDMR/PCA Shareholding
8th Jul 20257:00 amRNSTrading Update
26th Jun 20254:15 pmRNSDirector/PDMR Shareholding
25th Jun 20253:45 pmRNSHolding(s) in Company
25th Jun 202510:30 amRNSHolding(s) in Company
17th Jun 202511:45 amRNSHolding(s) in Company
2nd Jun 20257:00 amRNSTotal Voting Rights
28th May 20251:19 pmRNSHolding(s) in Company
27th May 202510:00 amRNSChange of Adviser
23rd May 202510:22 amRNSHolding(s) in Company
21st May 20255:15 pmRNSHolding(s) in Company
21st May 20255:15 pmRNSBlock Listing Application
21st May 20255:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.